|
Market Closed -
Swiss Exchange
20:30:30 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0226 CHF | +9.71% |
|
0.00% | -59.21% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.71% | 0.00% | +9.71% | -44.33% | -59.21% | -65.12% | -54.07% | -98.08% | -99.05% | 3.18M | |
| -0.62% | +0.50% | -11.61% | +12.26% | +56.67% | +33.92% | +60.07% | +2.90% | - | 64.38B | |
| +0.35% | +3.20% | -4.68% | +8.12% | +12.61% | +14.92% | +84.55% | +205.18% | +5,665.71% | 56.16B | |
| +0.53% | +1.96% | +12.00% | +12.98% | +19.78% | +15.37% | +106.81% | -15.59% | +244.86% | 54.16B | |
| -3.69% | -5.00% | -1.29% | +11.60% | +17.73% | +22.59% | +49.80% | +2.51% | +269.92% | 45.33B | |
| -0.47% | -1.60% | +1.54% | +15.37% | +22.31% | +20.56% | +99.13% | +3.95% | +1,017.90% | 42.25B | |
| -0.25% | +1.06% | -7.93% | -1.66% | +137.26% | +221.01% | +929.86% | +507.26% | - | 40.78B | |
| +3.27% | +47.96% | +66.97% | +112.15% | +92.99% | +112.67% | +96.48% | +36.35% | +249.91% | 33.8B | |
| +1.22% | -1.39% | +7.10% | +6.44% | +11.15% | +13.92% | +46.95% | +16.23% | +160.92% | 32.25B | |
| -1.29% | -1.72% | -16.86% | +12.95% | +41.48% | +21.00% | -6.85% | -62.43% | - | 23.57B | |
| -1.48% | -0.32% | -10.65% | -5.41% | -7.74% | -16.09% | -5.81% | -67.98% | - | 22.39B | |
| +1.01% | +20.69% | -1.25% | +11.06% | -35.24% | -41.97% | +373.57% | +263.00% | +768.34% | 24.37B | |
| -3.74% | -2.44% | +4.59% | +12.89% | +16.24% | +12.49% | +170.00% | +188.35% | +2,149.69% | 18.95B | |
| -5.65% | +2.59% | +20.10% | +51.01% | +77.61% | +97.81% | +115.35% | -19.53% | +366.92% | 17.95B | |
| +0.73% | +3.57% | +16.96% | +27.87% | +40.58% | +44.70% | +87.72% | -15.33% | +111.94% | 16.88B | |
| +7.19% | +10.65% | +22.25% | +27.58% | +62.91% | +83.37% | +252.79% | +229.06% | +574.27% | 16.4B | |
| -0.93% | +3.29% | +10.33% | +0.12% | - | - | - | - | - | 16.62B | |
| -2.79% | +12.87% | +23.01% | +26.33% | +14.76% | +26.48% | -12.19% | -27.62% | +160.48% | 16.14B | |
| -4.03% | +2.59% | -0.42% | +10.19% | +180.86% | +166.14% | +341.90% | +1,407.09% | +787.81% | 15.77B | |
| -7.79% | +6.05% | -12.45% | +61.90% | +21.43% | -16.88% | - | - | - | 14.05B | |
| Average | -0.46% | +5.78% | +6.37% | +18.47% | +38.12% | +40.36% | +152.00% | +141.96% | +887.83% | 28.61B | |
| Weighted average by Cap. | -0.65% | +5.03% | +4.56% | +19.31% | +41.45% | +45.10% | +163.36% | +120.88% | +1,262.00% |
- Stock Market
- Stocks
- ADXN Stock
- Sector Addex Therapeutics Ltd
Select your edition
All financial news and data tailored to specific country editions
